About Civica
Civica is a 501(c)(4) social welfare organization established in 2018 by health systems and philanthropies to reduce chronic generic drug shortages and related high prices in the United States. Civica is led by an experienced team of healthcare and pharmaceutical industry leaders.
Today, more than 55 health systems have joined Civica. They represent over 1,500 hospitals and one-third of all U.S. hospital beds. Civica has also begun to supply the U.S. Department of Veteran\xe2\x80\x99s Affairs, the U.S. Department of Defense and the U.S. Strategic National Stockpile of essential medicines.
Civica recently announced plans to expand its mission, via a unit called CivicaScript, to into the outpatient pharmacy space and to manufacture and distribute insulins that, once approved, will be available to people with diabetes at significantly lower prices than insulins currently on the market. The availability of Civica\xe2\x80\x99s affordable insulins, beginning in 2024, will benefit people with diabetes who have been forced to choose between life sustaining medicines and living expenses, particularly those uninsured or underinsured who often pay the most out of pocket for their medications.
Civica\xe2\x80\x99s mission is to ensure that quality generic medications are accessible and affordable to everyone. Since established, the #1 Policy for the Civica team has been \xe2\x80\x9cDo What Is in the Best Interest of Patients.\xe2\x80\x9d Civica\xe2\x80\x99s manufacturing facility in Petersburg, Virginia, is the future home of affordable insulin and essential sterile injectable medicines. The facility is currently in late-stage construction and hiring for the site is well-underway.
To find out more about how Civica\xe2\x80\x99s innovative model is directly impacting patient care, click to read a summary from the New England Journal of Medicine. ( )
To learn more about Civica\xe2\x80\x99s plans to bring affordable insulin to Americans living with diabetes, click to read an article in BioSpace.
( )
Position Summary
The Associate Quality Control Laboratory Analyst will join the Civica, Inc. (\xe2\x80\x9cCivica\xe2\x80\x9d) organization and its newly forming team at the Petersburg, Virginia site by bringing their knowledge and experience in service to patients and pursuit of excellence in quality and compliance. The Petersburg site serves as Civica\xe2\x80\x99s new fill finish facility dedicated to the manufacture and supply of essential generic and biosimilar insulin sterile injectable medications. Responsibilities of the position include performing testing on biological drug substances and sterile injectable products. Responsibilities also include maintenance of equipment.
The role is essential to assure the intended materials utilized for manufacturing are tested to ensure the finished product meets the applicable standards of identity, strength, quality, and purity. You will help Civica achieve its mission of delivering quality medicines that are available and affordable to everyone by complying with applicable regulatory standards (e.g., Current Good Manufacturing Practices, and FDA Guidance documents) and expectations for the development and reliable supply of quality medicines.
Essential Duties and Responsibilities
MNCJobz.com will not be responsible for any payment made to a third-party. All Terms of Use are applicable.